The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets are now available to both oncologists and cancer researchers.
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.
A mutation that leads to relapse in many leukemia patients also causes a weakness that could be exploited to kill the cancer cells, Columbia researchers have reported.
A new study shows how stress accelerates pancreatic cancer development. Beta blockers, which block stress hormones, may increase survival for patients with the disease.
The fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive and increasing the amount of fuel available for rampant cell growth.
Cancer researchers at Columbia have discovered three genes that undermine the DNA repair process and promote tumor formation in cells with BRCA mutations.
Using electron microscopy, CUIMC biologists have captured the first detailed images of a calcium membrane pore in action, revealing a potential target for treating cancer.
An individual’s own genes play a role in the response to immunotherapy drugs, researchers in the Herbert Irving Comprehensive Cancer Center have found.